St Luke's: Plasma therapy shows improvement in COVID patients
Doctors at St. Luke's Medical Center report improvements in COVID-19 patients who received convalescent plasma therapy.
Convalescent plasma therapy involves transfusing blood from recovered COVID-19 patients, which contains antibodies against the virus.
Dr. Mae Campomanes noted positive changes in biochemical parameters and oxygenation status among treated patients.
Hematologist Dr. Francisco Lopez observed improvements in chest x-rays and reduced inflammation biomarkers.
Patients on ventilators showed decreased oxygen requirements.
Despite these promising signs, doctors emphasize that further studies are needed to confirm the efficacy of the treatment.
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
Topics in this story
Explore more stories about these topics